Clinical utility of hereditary cancer panel testing: Impact of PALB2 , ATM , CHEK2 , NBN , BRIP1 , RAD51C , and RAD51D results on patient management and adherence to provider recommendations
Vysotskaia, Valentina, Kaseniit, K. Eerik, Bucheit, Leslie, Ready, Kaylene, Price, Kristin, Johansen Taber, KatherineLanguage:
english
Journal:
Cancer
DOI:
10.1002/cncr.32572
Date:
November, 2019
File:
PDF, 280 KB
english, 2019